Form 4: Masimo Executive Reports RSU Conversion Post-Merger
Statement of Changes in Beneficial Ownership
Charles Dadswell, EVP and General Counsel of Masimo, reports the conversion of restricted stock units following the company's acquisition by Danaher Corporation.
Summary
- Charles Dadswell, EVP and General Counsel of Masimo Corporation, filed a Form 4 regarding the disposition of restricted stock units (RSUs).
- The transaction occurred on June 10, 2026, following the completion of the merger between Masimo Corporation and Danaher Corporation.
- A total of 11,886 RSUs from an October 2025 grant and 10,261 RSUs from a March 2026 grant were disposed of as part of the merger conversion process.
- These RSUs were converted into Danaher Corporation RSUs based on a merger consideration of $180.00 per share.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing confirming the completion of a previously announced merger.
Positives
- The merger successfully closed, providing liquidity and a defined exit value of $180.00 per share for equity holders.
Negatives
- The reporting person no longer holds direct equity in Masimo Corporation as it is now a wholly owned subsidiary of Danaher Corporation.
Risks
- Integration risks associated with the transition of Masimo into a subsidiary of Danaher Corporation.
Future Outlook
Masimo is now a wholly owned subsidiary of Danaher Corporation; future performance will be integrated into Danaher's consolidated financial reporting.
Management Comments
- The transaction was executed pursuant to the Agreement and Plan of Merger dated February 16, 2026.
Industry Context
StockSavvy.ai notes that this filing confirms the finalization of a significant M&A event in the medical technology sector, reflecting ongoing consolidation trends where larger conglomerates like Danaher acquire specialized monitoring and healthcare technology firms.
Comparison to Industry Standards
- The $180.00 per share acquisition price represents a standard premium-based exit for shareholders in the medical device sector.
- The conversion of unvested equity into parent company equity is a standard practice in large-scale corporate acquisitions to ensure management retention during the integration phase.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Change in Control | Masimo Corporation became a wholly owned subsidiary of Danaher Corporation. | 2026-06-10 | Significant change in corporate structure and governance oversight. |
Stakeholder Impact
- Shareholders have received the merger consideration.
- Employees and executives are transitioning to the parent company's compensation structure.
Next Steps
- Integration of Masimo operations into Danaher Corporation structure.
Key Dates
| Date | Description |
|---|---|
| 2025-10-22 | Original grant date of the first batch of restricted stock units. |
| 2026-02-16 | Date of the Agreement and Plan of Merger. |
| 2026-03-06 | Original grant date of the second batch of restricted stock units. |
| 2026-06-10 | Effective date of the merger and transaction date for RSU conversion. |
| 2026-06-12 | Date of filing for the Form 4. |
Keywords
Masimo, Danaher, Merger, Form 4, RSU, Acquisition, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.